Literature DB >> 19344891

Generalized anxiety disorder is associated with metabolic syndrome in the Vietnam experience study.

Douglas Carroll1, Anna C Phillips, G Neil Thomas, Catharine R Gale, Ian Deary, G David Batty.   

Abstract

BACKGROUND: Few studies have explored the relationship between major mental health disorders and metabolic syndrome (MetS), although both have been linked to cardiovascular disease. The present study examined the cross-sectional associations of major depressive disorder (MDD) and generalized anxiety disorder (GAD) with MetS in a large study of male US veterans.
METHODS: The analyses were cross-sectional. Participants (n = 4256) were drawn from the Vietnam Experience Study. From military service files, telephone interviews, and a medical examination, occupational, socio-demographic, and health data were collected. One-year prevalence of MDD and GAD was determined with DSM-III criteria. Metabolic syndrome was ascertained from data on: body mass index, fasting blood glucose or a diagnosis of diabetes, blood pressure, high-density lipoprotein cholesterol, and triglyceride levels.
RESULTS: In models that adjusted for age (p = .01) and additionally for place of service, ethnicity, marital status, smoking, alcohol consumption, IQ at enlistment, household income in midlife, and education grade achieved (p = .02), GAD was positively associated with MetS. Major depressive disorder was not related to MetS.
CONCLUSIONS: Depression has very much been the focal condition for studies on mental health and physical health outcomes. The current data suggest that future research should perhaps pay equal attention to GAD.

Entities:  

Mesh:

Year:  2009        PMID: 19344891     DOI: 10.1016/j.biopsych.2009.02.020

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  36 in total

1.  Perifornical Urocortin-3 mediates the link between stress-induced anxiety and energy homeostasis.

Authors:  Yael Kuperman; Orna Issler; Limor Regev; Ifat Musseri; Inbal Navon; Adi Neufeld-Cohen; Shosh Gil; Alon Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

Review 2.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

3.  The effect of mindfulness meditation training on biological acute stress responses in generalized anxiety disorder.

Authors:  Elizabeth A Hoge; Eric Bui; Sophie A Palitz; Noah R Schwarz; Maryann E Owens; Jennifer M Johnston; Mark H Pollack; Naomi M Simon
Journal:  Psychiatry Res       Date:  2017-01-26       Impact factor: 3.222

4.  Associations of immunometabolic risk factors with symptoms of depression and anxiety: The role of cardiac vagal activity.

Authors:  Mandy X Hu; Brenda W J H Penninx; Eco J C de Geus; Femke Lamers; Dora C-H Kuan; Aidan G C Wright; Anna L Marsland; Matthew F Muldoon; Stephen B Manuck; Peter J Gianaros
Journal:  Brain Behav Immun       Date:  2018-06-18       Impact factor: 7.217

5.  Molecular mechanisms of D-cycloserine in facilitating fear extinction: insights from RNAseq.

Authors:  Stefanie Malan-Müller; Lorren Fairbairn; Willie M U Daniels; Mahjoubeh Jalali Sefid Dashti; Edward J Oakeley; Marc Altorfer; Martin Kidd; Soraya Seedat; Junaid Gamieldien; Sîan Megan Joanna Hemmings
Journal:  Metab Brain Dis       Date:  2015-09-23       Impact factor: 3.584

6.  Generalized Anxiety Disorder (GAD) and Comorbid Major Depression with GAD Are Characterized by Enhanced Nitro-oxidative Stress, Increased Lipid Peroxidation, and Lowered Lipid-Associated Antioxidant Defenses.

Authors:  Michael Maes; Kamila Landucci Bonifacio; Nayara Rampazzo Morelli; Heber Odebrecht Vargas; Estefânia Gastaldello Moreira; Drozdstoy St Stoyanov; Décio Sabbatini Barbosa; André F Carvalho; Sandra Odebrecht Vargas Nunes
Journal:  Neurotox Res       Date:  2018-05-07       Impact factor: 3.911

7.  Anxiety and depressive symptoms and medical illness among adults with anxiety disorders.

Authors:  Andrea N Niles; Halina J Dour; Annette L Stanton; Peter P Roy-Byrne; Murray B Stein; Greer Sullivan; Cathy D Sherbourne; Raphael D Rose; Michelle G Craske
Journal:  J Psychosom Res       Date:  2014-11-25       Impact factor: 3.006

8.  Childhood trauma and metabolic syndrome in men and women.

Authors:  Chioun Lee; Vera Tsenkova; Deborah Carr
Journal:  Soc Sci Med       Date:  2014-01-22       Impact factor: 4.634

9.  Potentially traumatic events and the risk of six physical health conditions in a population-based sample.

Authors:  Katherine M Keyes; Katie A McLaughlin; Ryan T Demmer; Magdalena Cerdá; Karestan C Koenen; Monica Uddin; Sandro Galea
Journal:  Depress Anxiety       Date:  2013-03-11       Impact factor: 6.505

Review 10.  Exaggerated neurobiological sensitivity to threat as a mechanism linking anxiety with increased risk for diseases of aging.

Authors:  Aoife O'Donovan; George M Slavich; Elissa S Epel; Thomas C Neylan
Journal:  Neurosci Biobehav Rev       Date:  2012-11-02       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.